By Drug Target Review2023-08-22T12:00:56
Using genetically modified human neural stem cells (hNSCs), researchers demonstrated that targeted manipulation of a specific gene expression within hNSCs can facilitate the restoration of damaged neural circuits and recovery of locomotor functions.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-01-06T16:37:30
Sponsored by Catalent
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2024-01-26T13:22:42
Sponsored by bit.bio
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud